GTGaoying Tang

Gaoying Tang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Gaoying Tang has a total of 52 co-authors. Here are the top co-authors by number of shared publications:

  • Pixin Ran

    State Key Laboratory of Respiratory Diseases National Clinical Research Center for Respiratory Diseases Guangzhou Institute of Respiratory Health The First Affiliated Hospital of Guangzhou Medical University Guangzhou Guangdong China

    5 shared publications
  • Yumin Zhou

    State Key Laboratory of Respiratory Disease & National Clinical Research Center for Respiratory Disease & National Center for Respiratory Medicine & Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China

    5 shared publications
  • Fan Wu

    State Key Laboratory of Respiratory Disease & National Clinical Research Center for Respiratory Disease & National Center for Respiratory Medicine & Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou, China

    4 shared publications
  • Jieqi Peng

    State Key Laboratory of Respiratory Diseases, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China

    4 shared publications
  • Kunning Zhou

    State Key Laboratory of Respiratory Disease & National Clinical Research Center for Respiratory Disease & National Center for Respiratory Medicine & Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou, China

    4 shared publications
  • Lifei Lu

    State Key Laboratory of Respiratory Disease & National Clinical Research Center for Respiratory Disease & National Center for Respiratory Medicine & Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, People’s Republic of China

    4 shared publications

Latest Publications

  • Open Access

    Different airflow obstruction severity grading methods and mortality: results from the UK Biobank study

    by Suyin Huang, Haiqing Li, Mingkai Huang, Juncheng Liang, Changxing Ou, Kunning Zhou, Xiaohui Wu, Qi Wan, Gaoying Tang, Fangyan Wu, et al.

  • Open Access

    Long-term variability of impulse oscillometry defined small airway dysfunction in participants with and without chronic obstructive pulmonary disease

    by Lifei Lu, Gaoying Tang, Qi Wan, Fan Wu, Zhishan Deng, Jieqi Peng, Cuiqiong Dai, Kunning Zhou, Xiaohui Wu, Si Li, et al.

    Background: Small airway dysfunction (SAD), as assessed by impulse oscillometry (IOS) (IOS-SAD), exhibits temporal variability and its long-term fluctuations may be linked to distinct clinical phenotypes. We investigated the associations of long-term variability in IOS-SAD with adverse clinical outcomes among participants with and without chronic obstructive pulmonary disease (COPD). Methods: The baseline and 2-year follow-up data from the early COPD cohort were retrospectively analysed. SAD was defined based on the following criteria: difference from R5 to R20 (R5-R20) >upper limit of normal (ULN) (R5-R20-SAD), or reactance at 5 Hz (X5) ULN. Individuals were classified into three groups based on SAD variability over three visits at 2-year follow-up: (1) consistent SAD (SAD at every visit), (2) inconsistent SAD (SAD at some, but not all, visits) and (3) never SAD (no SAD at any visit). Differences in the rate of spirometric lung function decline and exacerbation rate were compared across long-term IOS-SAD variability groups in participants with and without COPD. Results: In individuals with COPD, the consistent and inconsistent SAD groups assessed were associated with a faster spirometric lung function decline and a higher risk of exacerbations. In individuals without COPD, the consistent R5-R20-SAD group was associated with a faster decline in spirometric lung function and progression towards COPD. Conclusions: SAD, even diagnosed once, characterises an airway behaviour with a higher proportion of higher risk of moderate or severe exacerbations. Consistent SAD was associated with accelerated spirometric lung function decline, increased exacerbation risk and progression to spirometry-defined COPD. Trial registration number: ChiCTR1900024643.


  • Open Access

    Assessment of the clinical prognosis of patients with chronic obstructive pulmonary disease using combined blood and sputum eosinophil counts

    by Jieqi Peng, Xiaohui Wu, Xiang Wen, Zhishan Deng, Fan Wu, Qi Wan, Gaoying Tang, Kunning Zhou, Lifei Lu, Cuiqiong Dai, et al.

    Background: High blood or sputum eosinophil counts are linked to poor clinical outcomes in chronic obstructive pulmonary disease (COPD), yet the value of combining both for the assessment of clinical prognosis remains unclear. In this study, we explore the value of combined blood and sputum eosinophil counts for assessing COPD outcomes. Methods: Patients were divided into four groups by blood (≥300 cells/µL) and sputum (≥3%) eosinophil counts (low blood and low sputum, low blood and high sputum, high blood and low sputum, high blood and high sputum). Spirometry, questionnaires, CT scans, impulse oscillometry, blood laboratory tests and induced sputum tests were performed at baseline. Spirometry and follow-up questionnaires were performed annually. Poisson regression was used to compute the relative risk (RR) for acute exacerbation. The mixed-effects model was used to assess annual lung function decline. Results: Compared with the low blood and low sputum eosinophils group, the high blood and high sputum eosinophils group had poorer lung function, more severe airway resistance and worse emphysema and air trapping at baseline. The high blood and high sputum eosinophils group had higher risks of cough (adjusted OR=1.87, 95% CI 1.20 to 2.92, p=0.006) and wheezing (adjusted OR=2.19, 95% CI 1.32 to 3.64, p=0.002). The low blood and high sputum eosinophils group had higher risks of phlegm (adjusted OR=1.53, 95% CI 1.04 to 2.24, p=0.029) and dyspnoea (adjusted OR=1.68, 95% CI 1.13 to 2.50, p=0.010). The high blood and high sputum eosinophils group demonstrated higher total (adjusted RR=1.36, 95% CI 1.15 to 1.60, p<0.001) and moderate-to-severe (adjusted RR=1.42, 95% CI 1.14 to 1.76, p=0.001) exacerbation risks. There was no significant difference in annual lung function decline among the groups. Conclusion: Elevated blood and sputum eosinophil counts are linked to worse lung function and a higher exacerbation risk in patients with COPD.


  • Discriminative Accuracy of Simplified Spirometry for Identifying Spirometry-Defined COPD in the Community

    by Fan Wu, Gaoying Tang, Zhishan Deng, Qi Wan, Kunning Zhou, Heshen Tian, Binwei Hao, Cuiqiong Dai, Zihui Wang, Siqi Zou, et al.


  • Top Cited Papers
    Open Access

    Associations of anxiety and depression with prognosis in chronic obstructive pulmonary disease: A systematic review and meta-analysis

    by Kefan Wu, Lifei Lu, Yubiao Chen, Jieqi Peng, Xiaohui Wu, Gaoying Tang, Ting Ma, Jing Cheng, Pixin Ran, Yumin Zhou

    The associations between anxiety, depression, and the prognosis of COPD remain uncertain. The present study aims to investigate the associations of anxiety and depression with 30-day readmission rates and acute exacerbations of COPD (AECOPD). Four databases were searched to identify relevant studies published before 13 March 2024. Studies that report on the impact of anxiety and depression on the prognosis of AECOPD were included. The pooled effect size and its 95% confidence interval (CI) were calculated using a random effects model. The primary outcomes were 30-day readmission and AECOPD within the first year after discharge in COPD patients. Of the 5,955 studies screened, 14 studies were included in the analysis. Patients with anxiety had a higher risk of AECOPD within the first year after discharge compared to those without anxiety (HR: 2.10, 95% CI: 1.28-3.45, p = 0.003). Patients with depression also had a higher risk of AECOPD within the first year after discharge (HR: 1.36, 95% CI: 1.10-1.69, p = 0.004). Similar results were observed in the associations of anxiety and depression with 30-day readmission. Our results suggested that anxiety and depression were associated with an increased risk of 30-day readmission and AECOPD in patients with COPD.


  • Open Access

    Clinical characteristics and longitudinal prognosis of patients with mild-to-moderate chronic obstructive pulmonary disease progressing from different lung function trajectories

    by Xiaozi Guo, Fan Wu, Yingtong Chen, Qiaorui Zhou, Zhishan Deng, Qi Wan, Gaoying Tang, Lifei Lu, Kunning Zhou, Cuiqiong Dai, et al.

    Lung function trajectories in chronic obstructive pulmonary disease (COPD) vary among individuals. However, evidence on the clinical characteristics and prognosis of mild-to-moderate COPD developing from different lung function trajectories is limited. We aim to explore whether differences exist in the clinical features and prognosis of mild-to-moderate COPD developed through different lung function trajectories. Individuals who participated in the Early COPD study (2019–2020) and who had available spirometry data from the China Epidemiological Survey of COPD (2012–2013) were included and categorized into three groups: (I) previously normal forced expiratory volume in one second (FEV1) trajectory group: participants had developed mild-to-moderate COPD in 2019–2020, with normal lung function in 2012–2013; (II) previously low FEV1 trajectory group: participants had developed mild-to-moderate COPD in 2019–2020, with subnormal lung function in 2012–2013; (III) non-COPD group: participants had not developed COPD in 2019–2020, with normal lung function in 2012–2013. Baseline assessments (2019–2020) included spirometry, impulse oscillometry (IOS), and chest computed tomography (CT). Lung function decline and exacerbation risk were analyzed over a 2-year follow-up (2021–2022). Overall, 96 participants were included in the previously normal FEV1 trajectory group, 32 in the previously low FEV1 trajectory group, and 118 in the non-COPD group. Compared with the previously normal FEV1 trajectory group, the previously low FEV1 trajectory group had poorer lung function, more severe dyspnea, and greater small-airway dysfunction and emphysema. During the 2-year follow-up, the previously normal FEV1 trajectory group had a faster annual rate of forced vital capacity (FVC) decline, and the previously low FEV1 trajectory group had a higher moderate-to-severe exacerbation risk than the non-COPD group. There were significant differences in the clinical characteristics and longitudinal prognosis of mild-to-moderate COPD progressing from different pulmonary function trajectories, reflecting the need for individualized management.